Radisys Celebrates Six Engage Digital Platform Winners of TADHack 2022 Hackathon
8.11.2022 22:30:00 EET | Business Wire | Press release
Radisys® Corporation, a global leader of open telecom solutions, is pleased to highlight the winners of the Engage Digital Platform real-world solutions in the 2022 TADHack Global, a hackathon focused on programmable communication solutions. Radisys provided participants in the Telecom Application Development (TAD) with access to its award-winning, no-code or low-code Engage Digital Platform to develop software projects or “hacks” that address customer challenges or use cases. Radisys’ Engage Digital Platform provides developers with a complete toolkit to create a full range of communication services, from voice and video calling, speech analytics and robust conversational AI-enabled digital engagement solutions.
The TADHack Global hackathon took place October 15-16, 2022, with participants competing across several cities and online. Radisys selected six winners, including a tie for third place and two specialized categories, for the best hacks from among the 23 submissions using Radisys’ Engage Digital Platform.
“I want to congratulate all of the 2022 TADHack Global event winners, especially those teams that leveraged Radisys’ Engage Digital Platform to develop such innovative solutions,” said Al Balasco, Head of Media, Core and Applications Business, Radisys. “The development of these amazing real-world solutions over a weekend was impressive and underscores the speed at which new ideas and applications can be developed and implemented. Hackathons like TADHack are a great way to showcase how MSPs and system integrators can benefit from an innovative developer ecosystem that is equipped with APIs and SDKs to create powerful advanced media applications they can integrate and offer as new services.”
Engage Digital Platform TADHack Global Winners
- First Place – Field Workforce Helper provides information from the inventory to support field workforce tasks, and routes Guard calls to the guard operator using an agenda in a Google spreadsheet, finally logging the call information in the spreadsheet. Team Member: Nacho Garmilla.
- Second Place – Secret Babble makes multilingual conversations more accessible by providing translations over the phone which can be read out loud by the system or sent discreetly as a text message, providing a transcription of the exchange. Team: Similarly Geeky; Team Members: Steve Goodwin & Lily Madar.
- Third Place – Blink is an application for crowded places designed to reduce the crowd and give people easy access to information about that particular place. It is used in places like hospitals, banks, shops, and airports, etc. Team: Sibane IT Solutions; Team Member: Linda Mosemaka.
- Third Place – Live Connect lets users connect to experts around the world for things such as learning a new language or finding a math or music tutor, to getting golf swing help and anything in between. Live Connect helps users find a suitable expert, book an appointment and connect via computer or phone using Radisys video APIs to bring the expert into customers’ homes. Team: Live Connect; Team Member: John Cakesy.
- Best Industry 4.0 Hack – FiremeX is a fire detection and alerting system that integrates computer vision, alert notifications and real-time audio calling when an event is detected. Team: RegeX; Team members: Nandula Perera, Raveen Fernando, Suvin Kodituwakku, Dilan Perera, Thenuka Ovin Weerasinghe.
- Disruptive Digital Engagement Hack – LifeVerse is a real-time health engagement platform that enables different types of clinics to be created and managed in the metaverse for both appointments and real-time consultations with patients. Team: LifeVerse; Team Members: Fahad Mahmood, Sarmad Faheem, Faheem Azhar.
To view videos of the six Engage Digital Platform winners and see all of the TADHack 2022 hacks visit https://www.engagedigital.ai/tadhack22.
About Radisys
Radisys, a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business models. Radisys’ innovative disaggregated and virtualized enabling technology solutions leverage open reference architectures and standards, combined with open software and hardware to power business transformation for the telecom industry, while its world-class services organization delivers systems integration expertise necessary to solve communications and content providers’ complex deployment challenges. For more information, visit www.radisys.com.
Radisys Engage Digital Platform was named both a 2022 Unified Communications Product of the Year Award winner and a Communications Product of the Year Award winner by TMC, a global, integrated media company covering multiple markets within the communications and technology industries, and won the Innovation in Digital Experience award in the 2022 Pipeline Innovation Awards, which recognizes the leading innovators transforming the industry with the most significant technological advancements. Engage Digital Platform was also named a “Highly Commended Best Comms Software” by the 2022 Comms Council UK Awards, a celebration of innovation in the telecom industry, and was selected as a finalist in the Best CPaaS Platform Award category by UC Today, a leading online publication for unified communications (UC) and collaboration technology. For more information, visit www.engagedigital.ai.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108006102/en/
Contact information
Nereus for Radisys
Matt Baxter, +1-503-619-0505
radisys@nereus-worldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom